AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Rushmie Nofsinger -- Executive Director of Corporate Communications &
AMAG Pharmaceuticals Inc.
-(AMAG)
XWBO:AMAG
AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) Q1 2020 Earnings Call Transcript
AMAG Pharmaceuticals Inc. (AMAG) Q1 2020 earnings call dated May 11, 2020 Corporate Participants: Linda Lennox -- Vice President of Investor Relations and Corporate
AMAG Pharmaceuticals (AMAG) Q4 2019 Earnings Snapshot
-- AMAG Pharmaceuticals (NASDAQ: AMAG) reported a net loss of $199.9 million or $5.89 per share for the fourth quarter of 2019
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG): Q3 2019 Earnings Snapshot
-- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) reported a net loss of $23.62 million or $0.70 per share for the third quarter of